Correlation Between Arcus Biosciences and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Hookipa Pharma, you can compare the effects of market volatilities on Arcus Biosciences and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Hookipa Pharma.
Diversification Opportunities for Arcus Biosciences and Hookipa Pharma
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Arcus and Hookipa is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Hookipa Pharma
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.87 times more return on investment than Hookipa Pharma. However, Arcus Biosciences is 1.15 times less risky than Hookipa Pharma. It trades about -0.04 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.46 per unit of risk. If you would invest 1,666 in Arcus Biosciences on August 29, 2024 and sell it today you would lose (87.00) from holding Arcus Biosciences or give up 5.22% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcus Biosciences vs. Hookipa Pharma
Performance |
| Timeline |
| Arcus Biosciences |
| Hookipa Pharma |
Arcus Biosciences and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and Hookipa Pharma
The main advantage of trading using opposite Arcus Biosciences and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |